Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
More than two years after the World Health Organization (WHO) declared an end to the emergency phase of the Covid-19 pandemic ...
The assay is the first to receive FDA 510(k) clearance and CLIA waiver for use with Diasorin's Liaison Nes platform.
Earlier this week, another case of foot-and-mouth disease (FMD) was identified, this time in Amahlati Local Municipality, in the Amathole District, Eastern Cape. Chief State Veterinarian Dr Ayla ...
Police received a PCR call around 10.46 am on December 27 regarding the murder in Mansa Ram Park in Bindapur, following which ...
WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...
WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.
Background Evidence impact of the COVID-19 pandemic on health-related indicator in Sub-Saharan Africa is limited. We aimed to ...
Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...
NEW YORK – Fulgent Genetics announced on Monday that it has entered into a definitive agreement to acquire lab service provider StrataDx, as well as certain assets of Bako Diagnostics. Fulgent said it ...
Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...
The world of medical testing is always changing, and point-of-care molecular diagnostics are a big part of that. These tests let us find out what’s going on with a patient’s health right there, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback